| Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial SV Navarra, RM Guzmán, AE Gallacher, S Hall, RA Levy, RE Jimenez, ... The Lancet 377 (9767), 721-731, 2011 | 2092 | 2011 |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ... Annals of the rheumatic diseases 73 (6), 958-967, 2014 | 797 | 2014 |
| Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients RA Asherson, R Cervera, JC Piette, J Font, JT Lie, A Burcoglu, K Lim, ... Medicine 77 (3), 195-207, 1998 | 700 | 1998 |
| Anti-inflammatory and immunosuppressive drugs and reproduction M Østensen, M Khamashta, M Lockshin, A Parke, A Brucato, H Carp, ... Arthritis research & therapy 8, 1-19, 2006 | 675 | 2006 |
| Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study G Singh, JG Fort, JL Goldstein, RA Levy, PS Hanrahan, AE Bello, ... The American journal of medicine 119 (3), 255-266, 2006 | 499 | 2006 |
| Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study RA Levy, VS Vilela, MJ Cataldo, RC Ramos, JLMB Duarte, BR Tura, ... Lupus 10 (6), 401-404, 2001 | 463 | 2001 |
| Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double‐blind, placebo‐controlled trial in asymptomatic antiphospholipid antibody … D Erkan, MJ Harrison, R Levy, M Peterson, M Petri, L Sammaritano, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 459 | 2007 |
| A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) R Van Vollenhoven, A Voskuyl, G Bertsias, C Aranow, M Aringer, ... Annals of the rheumatic diseases 76 (3), 554-561, 2017 | 370 | 2017 |
| 14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends D Erkan, CL Aguiar, D Andrade, H Cohen, MJ Cuadrado, A Danowski, ... Autoimmunity reviews 13 (6), 685-696, 2014 | 280 | 2014 |
| Willis R1, Lockshin MD D Erkan, CL Aguiar, D Andrade, H Cohen, MJ Cuadrado, A Danowski, ... 14th International Congress on Antiphospholipid Antibodies: task force …, 2014 | 263 | 2014 |
| The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th international congress on antiphospholipid antibodies technical task force report on … MM Abreu, A Danowski, DG Wahl, MC Amigo, M Tektonidou, MS Pacheco, ... Autoimmunity reviews 14 (5), 401-414, 2015 | 248 | 2015 |
| Autoimmunity: from bench to bedside [Internet] JM Anaya, Y Shoenfeld, A Rojas-Villarraga, RA Levy, R Cervera El Rosario University Press, 2013 | 243 | 2013 |
| Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials MA Petri, RF Van Vollenhoven, J Buyon, RA Levy, SV Navarra, R Cervera, ... Arthritis & Rheumatism 65 (8), 2143-2153, 2013 | 201 | 2013 |
| Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. S Garcia, JH Nascimento, E Bonfa, R Levy, SF Oliveira, AV Tavares, ... The Journal of clinical investigation 93 (2), 718-724, 1994 | 172 | 1994 |
| Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus … V Strand, RA Levy, R Cervera, MA Petri, H Birch, WW Freimuth, ZJ Zhong, ... Annals of the rheumatic diseases 73 (5), 838-844, 2014 | 162 | 2014 |
| Treatment of pregnant patients with antiphospholipid syndrome A Tincani, W Branch, RA Levy, JC Piette, H Carp, RS Rai, M Khamashta, ... Lupus 12 (7), 524-529, 2003 | 155 | 2003 |
| First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano … BA Pons-Estel, E Bonfa, ER Soriano, MH Cardiel, A Izcovich, F Popoff, ... Annals of the rheumatic diseases 77 (11), 1549-1557, 2018 | 153 | 2018 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 141 | 2023 |
| Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus DJ Wallace, S Navarra, MA Petri, A Gallacher, M Thomas, R Furie, ... Lupus 22 (2), 144-154, 2013 | 131 | 2013 |
| Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation RA Levy, GR de Jesús, NR de Jesús, EM Klumb Autoimmunity reviews 15 (10), 955-963, 2016 | 113 | 2016 |
Guilherme Ramires de JesúsProfessor Adjunto, Universidade do Estado do Rio de Janeiro. Médico Obstetra, Instituto FernandesVerified email at hupe.uerj.br
